Pietro Lampertico

Preliminary monocentric survey on the prevalence of HBV seropositivity in HSCT recipients (2009)

ONIDA, FRANCESCO, LAMBERTENGHI DELILIERS, GIORGIO, LAMPERTICO, PIETRO

Preliminary monocentric survey on the prevalence of HBV seropositivity in HSCT recipients / P. Usardi, C. Annaloro, M. Viganò, P. Lampertico, F. Onida, E. Tagliaferri, A. Della Volpe, G....

Partial virological response to nucleos(t)ide analogues in naive patients with chronic hepatitis B: From guidelines to field practice (2009)

LAMPERTICO, PIETRO, P. Lampertico

Partial virological response to nucleos(t)ide analogues in naive patients with chronic hepatitis B: From guidelines to field practice / P. Lampertico. - In: Journal of Hepatology. - 50:4(2009 Apr). -...

HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, P. Lampertico, M. Colombo

HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues / P. Lampertico, M. Colombo. - In: Liver International. - ISSN 1478-3223. - 29:S1(2009). - p. 130-132.

High risk of renal impairment during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B (2009)

COLOMBO, MASSIMO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, LAMPERTICO, PIETRO, TONTINI, GIAN EUGENIO, FACCHETTI, FLORIANA, ...

High risk of renal impairment during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B / M. Viganò, P. Lampertico, M. Iavarone, G.E....

Prospective study of dysplastic nodules in cirrhosis : correlation with CT vascular pattern, histology and development of hepatocellular carcinoma (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO, AGHEMO, ALESSIO MICHELE

Prospective study of dysplastic nodules in cirrhosis : correlation with CT vascular pattern, histology and development of hepatocellular carcinoma / M. Iavarone, A. Sangiovanni, G. Ronchi, L.V....

Effectiveness of entecavir for the treatment of nuc-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, FACCHETTI, FLORIANA, FARGION, SILVIA ROSSANA, ...

Effectiveness of entecavir for the treatment of nuc-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice / P. Lampertico, M. Viganò, F. Facchetti, E. Minola,...

Changes in liver stiffness during entecavir therapy in patients with chronic hepatitis B (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, CONTE, DARIO, DELLA VALLE, SERENA

Changes in liver stiffness during entecavir therapy in patients with chronic hepatitis B / M. Viganò, S. Massironi, P. Lampertico, M. Fraquelli, S. Della Valle, P. Del Poggio, D. Conte, M. Colombo....

High risk of renal impairment during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, FACCHETTI, FLORIANA, TONTINI, GIAN EUGENIO, ...

High risk of renal impairment during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B / M. Viganò, P. Lampertico, M. Iavarone, G.E....

Effectiveness of entecavir for the treatment of NUC-naïve chronic hepatitis B patients : A large multicenter cohort study in clinical practice (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, FACCHETTI, FLORIANA, FATTA, ERIKA, ...

Effectiveness of entecavir for the treatment of NUC-naïve chronic hepatitis B patients : A large multicenter cohort study in clinical practice / P. Lampertico, M. Viganò, F. Facchetti, E. Minola,...

Transient elastography predicts response to prolonged therapy with a nucleoside analog in patients with chronic hepatitis B (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, CONTE, DARIO, DELLA VALLE, SERENA

Transient elastography predicts response to prolonged therapy with a nucleoside analog in patients with chronic hepatitis B / M. Viganò, S. Massironi, P. Lampertico, M. Fraquelli, S. Della Valle, P....

Changes in liver stiffness during entecavir therapy in patients with chronic hepatitis B (2009)

COLOMBO, MASSIMO, VIGANO', MAURO, LAMPERTICO, PIETRO, CONTE, DARIO, DELLA VALLE, SERENA

Changes in liver stiffness during entecavir therapy in patients with chronic hepatitis B / M. Viganò, S. Massironi, P. Lampertico, M. Fraquelli, S. Della Valle, P. Del Poggio, D. Conte, M. Colombo....

High risk of renal impairment during long-term adefovir and lamivudine combination therapy in patients with lamivudineresistant chronic hepatitis B (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, FACCHETTI, FLORIANA, TONTINI, GIAN EUGENIO, ...

High risk of renal impairment during long-term adefovir and lamivudine combination therapy in patients with lamivudineresistant chronic hepatitis B / M. Viganò, P. Lampertico, M. Iavarone, G.E....

Entecavir is an effective treatment for NUC-naive chronic hepatitis B patients in clinical practice : 48-week data from a large multicenter cohort study (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, FACCHETTI, FLORIANA, FARGION, SILVIA ROSSANA, ...

Entecavir is an effective treatment for NUC-naive chronic hepatitis B patients in clinical practice : 48-week data from a large multicenter cohort study / P. Lampertico, M. Viganò, F. Facchetti, F....

Prospective study of dysplastic nodules in cirrhosis : correlation with CT vascular pattern, histology and development of hepatocellular carcinoma (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO, AGHEMO, ALESSIO MICHELE

Prospective study of dysplastic nodules in cirrhosis : correlation with CT vascular pattern, histology and development of hepatocellular carcinoma / M. Iavarone, A. Sangiovanni, G. Ronchi, L.V....

Lamivudine prophylaxis of hepatitis B reactivation in anti-HBC seroposivive patients undergoing chemotherapy for onco-hematological diseases (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, FACCHETTI, FLORIANA, OLIVERO, BARBARA, VINCENTI, DANIELE, ...

Lamivudine prophylaxis of hepatitis B reactivation in anti-HBC seroposivive patients undergoing chemotherapy for onco-hematological diseases / M. Viganò, B. Olivero, P. Lampertico, D. Vincenti, M.C....

Progressive decline of HBsAg titers in long-term virological responders to nucleos(t)ide analogue therapy for chronic hepatitis B (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Progressive decline of HBsAg titers in long-term virological responders to nucleos(t)ide analogue therapy for chronic hepatitis B / M. Iavarone, P. Lampertico, M. Vigano, F. Facchetti, G. Lunghi, S....

Independent influencers of transient elastography assessment of liver fibrosis in hepatitis B and hepatitis C patients (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, RUMI, MARIAGRAZIA, CONTE, DARIO

Independent influencers of transient elastography assessment of liver fibrosis in hepatitis B and hepatitis C patients / M. Fraquelli, C. Rigamonti, G. Casazza, M.F. Donato, D. Conte, G. Ronchi, S....

HBV and HCV Therapy (2009)

Pietro Lampertico, Alessio Aghemo, Mauro Viganò, Massimo Colombo

One year of interferon therapy inhibits HBV replication in one third of the patients whereas long-term administration of oral nucleos(t)ide analogues is efficient in most of them, as long as early...

The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirin (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, RUMI, MARIAGRAZIA, IAVARONE, MASSIMO ALBERTO

The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirin / M. Viganò, A. Aghemo, M. Iavarone, M.G. Rumi, F. Agnelli, P. Lampertico, M.F. Donato, M....

HBV and HCV Therapy (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO

HBV and HCV Therapy / P. Lampertico, A. Aghemo, M. Viganò, M. Colombo. - In: Viruses. - ISSN 1999-4915. - 1:3(2009). - p. 484-509.

Entecavir for nuc-naïve chronic hepatitis B patients in clinical practice : long-term effectiveness from a large multicenter cohort study in 376 patients (2009)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, FACCHETTI, FLORIANA, FARGION, SILVIA ROSSANA, FATTA, ERIKA, ...

Entecavir for nuc-naïve chronic hepatitis B patients in clinical practice : long-term effectiveness from a large multicenter cohort study in 376 patients / P. Lampertico, M. Viganò, F. Facchetti,...

Failure of adefovir 20 mg to improve suboptimal response in lamivudine resistant hepatitis B patients treated with adefovir 10 mg and lamivudine (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO

Failure of adefovir 20 mg to improve suboptimal response in lamivudine resistant hepatitis B patients treated with adefovir 10 mg and lamivudine / M. Viganò, P. Lampertico, F. Facchetti, G. Lunghi,...

Acute hepatitis following assumption of a herbal remedy (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO

Acute hepatitis following assumption of a herbal remedy / M. Viganò, P. Lampertico, M. Colombo. - In: European Journal of Gastroenterology and Hepatology. - ISSN 0954-691X. - 20:4(2008). - p....

The natural history of portal hypertension in patients with HCV related compensated cirrhosis undergoing interferon ribavirin therapy (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, RUMI, MARIAGRAZIA, AGHEMO, ALESSIO MICHELE, D'AMBROSIO, ROBERTA, DELL'ERA, ALESSANDRA, ...

The natural history of portal hypertension in patients with HCV related compensated cirrhosis undergoing interferon ribavirin therapy / R. D’Ambrosio, A. Aghemo, M.G. Rumi, M. Primignani, A....

Graft dysfunction (GD) in HBV recurrence free recipience is associated with serum autoantibodies reactivity (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, ROSSI, GIORGIO ETTORE, AROSIO, ELIANA

Graft dysfunction (GD) in HBV recurrence free recipience is associated with serum autoantibodies reactivity / M.F. Donato, E. Arosio, F. Agnelli, C. Rigamonti, M. Viganò, L. Caccamo, P. Lampertico,...

Independent predictors of discordance between transient elastography (TE) and liver biopsy (LB) (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, RUMI, MARIAGRAZIA, CONTE, DARIO

Independent predictors of discordance between transient elastography (TE) and liver biopsy (LB) / M. Fraquelli, C. Rigamonti, D. Conte, G. Casazza, M.F. Donato, M.G. Rumi, P. Lampertico, G. Ronchi,...

Low risk of hepatocellular carcinoma recurrence after liver transplantation : a 3-year follow-up study in 78 patients with chronic hepatitis B (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, ROSSI, GIORGIO ETTORE

Low risk of hepatocellular carcinoma recurrence after liver transplantation : a 3-year follow-up study in 78 patients with chronic hepatitis B / P. Lampertico, M. Viganò, S. Bhoori, F. Agnelli, M.F....

Add on Adefovir prevents the emergence of ADV resistance in Lamivudine-resistant patients : a 4-year study (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Add on Adefovir prevents the emergence of ADV resistance in Lamivudine-resistant patients : a 4-year study / P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, M. Colombo. - In: Journal of...

Independent predictors of discordance between transient elastography (TE) and liver biopsy (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, RUMI, MARIAGRAZIA, CONTE, DARIO

Independent predictors of discordance between transient elastography (TE) and liver biopsy / M. Fraquelli, C. Rigamonti, G. Casazza, M.F. Donato, D. Conte, S. Massironi, M.G. Rumi, P. Lampertico, G....

Very early add-on adefovir therapy in patients with sub-optimal virological response to lamivudine (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Very early add-on adefovir therapy in patients with sub-optimal virological response to lamivudine / M. Viganò, M. Iavarone, M. Colombo, P. Lampertico. - In: Digestive and liver disease : an...

Four years of Adefovir add-on in 145 lamivudine resistant patients with chronic hepatitis B : low risk of genotypic resistance to ADV and prevention of virologic breakthrough (2008)

LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO, COLOMBO, MASSIMO

Four years of Adefovir add-on in 145 lamivudine resistant patients with chronic hepatitis B : low risk of genotypic resistance to ADV and prevention of virologic breakthrough / P. Lampertico, M....

Low risk of hepatitis B reactivatioin in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, RUMI, MARIAGRAZIA, VIGANO', MAURO, AGHEMO, ALESSIO MICHELE, IAVARONE, MASSIMO ALBERTO, ...

Low risk of hepatitis B reactivatioin in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin / A. Aghemo, M. Viganò, M. Iavarone,...

Low risk of hepatitis B reactivation in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, RUMI, MARIAGRAZIA, IAVARONE, MASSIMO ALBERTO, AGHEMO, ALESSIO MICHELE, ...

Low risk of hepatitis B reactivation in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin / M. Iavarone, A. Aghemo, M. Viganò,...

Prospective study of dysplastic nodes in cirrhotic patients : correlation with CT vascular pattern (2008)

COLOMBO, MASSIMO, AGHEMO, ALESSIO MICHELE, LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO

Prospective study of dysplastic nodes in cirrhotic patients : correlation with CT vascular pattern / M. Iavarone, A. Sangiovanni, G. Ronchi, L.V. Forzenigo, A. Aghemo, P. Lampertico, M. Colombo. -...

Maintained HBV suppression in lamivudine-resistant patients treated with adefovir and lamivudine combination : A 4- year cohort study in 63 patients (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Maintained HBV suppression in lamivudine-resistant patients treated with adefovir and lamivudine combination : A 4- year cohort study in 63 patients / P. Lampertico, M. Viganò, E. Manenti, M....

Transient elastography (TE) accurately predicts liver fibrosis stage in patients with chronic hepatitis B (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, CONTE, DARIO, PIROLA, LORENA, ...

Transient elastography (TE) accurately predicts liver fibrosis stage in patients with chronic hepatitis B / M. Viganò, S. Massironi, P. Lampertico, S. Paggi, M. Iavarone, L. Pirola, P. Del Poggio,...

Excellent 5-year overall survival in patients with HBV-related cirrhosis undergoing liver transplantation for hepatocellular carcinoma (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, BHOORI, SHERRIE, BONGINI, MARCO ANGELO, ...

Excellent 5-year overall survival in patients with HBV-related cirrhosis undergoing liver transplantation for hepatocellular carcinoma / P. Lampertico, M. Viganò, S. Bhoori, F. Agnelli, M.F. Donato,...

High risk of renal impairment and arterial hypertension during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, TONTINI, GIAN EUGENIO

High risk of renal impairment and arterial hypertension during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B / M. Viganò, P....

Effectiveness of Entecavir for the treatment of NUC-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, FARGION, SILVIA ROSSANA, FATTA, ERIKA

Effectiveness of Entecavir for the treatment of NUC-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice / P. Lampertico, M. Viganò, F. Facchetti, M. Puoti, E....

Progressive decline of HBsAg titers in longterm virological responders to nucleos(t)ide analogue therapy for chronic hepatitis B (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Progressive decline of HBsAg titers in longterm virological responders to nucleos(t)ide analogue therapy for chronic hepatitis B / M. Iavarone, P. Lampertico, M. Viganò, F. Facchetti, S. Melotti, G....

The use of molecular assays in the management of viral hepatitis (2008)

LAMPERTICO, PIETRO

The use of molecular assays in the management of viral hepatitis / A. Mangia, F. Antonucci, M. Brunetto, M. Capobianchi, S. Fagiuoli, M. Guido, P. Farci, P. Lampertico, A. Marzano, G. Niro, G....

Hepatotropic viruses : new insights in pathogenesis and treatment (2008)

LAMPERTICO, PIETRO

Hepatotropic viruses : new insights in pathogenesis and treatment / A. Gatta, C. Giannini, P. Lampertico, P. Pontisso, S. Quarta, A.L. Zignego, F. Atzeni, P. Sarzi Puttini. - In: Clinical and...

Hepatitis B virus infection in the dialisi population : current perspectives (2008)

LAMPERTICO, PIETRO

Hepatitis B virus infection in the dialisi population : current perspectives / F. Fabrizi, A. Marzano, P. Messa, P. Martin, P. Lampertico. - In: The international journal of artificial organs. - ISSN...

Failure of adefovir 20 mg to improve suboptimal response in lamivudine resistant hepatitis B patients treated with adefovir 10 mg and lamivudine (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, FACCHETTI, FLORIANA

Failure of adefovir 20 mg to improve suboptimal response in lamivudine resistant hepatitis B patients treated with adefovir 10 mg and lamivudine / M. Viganò, P. Lampertico, F. Facchetti, G. Lunghi,...

Four years of Adefovir add-on in 145 lamivudine resistant patients with chronic hepatitis B : low risk of genotypic resistance to ADV and prevention of virologic breakthrough (2008)

LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO, COLOMBO, MASSIMO, FACCHETTI, FLORIANA, VIGANO', MAURO

Four years of Adefovir add-on in 145 lamivudine resistant patients with chronic hepatitis B : low risk of genotypic resistance to ADV and prevention of virologic breakthrough / P. Lampertico, M....

Effectiveness of Entecavir for the treatment of NUC-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, FARGION, SILVIA ROSSANA, FATTA, ERIKA, FACCHETTI, FLORIANA, ...

Effectiveness of Entecavir for the treatment of NUC-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice / P. Lampertico, M. Viganò, F. Facchetti, M. Puoti, E....

High risk of renal impairment and arterial hypertension during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, TONTINI, GIAN EUGENIO, FACCHETTI, FLORIANA, ...

High risk of renal impairment and arterial hypertension during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B / M. Viganò, P....

Acute hepatitis following assumption of a herbal remedy (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO

Acute hepatitis following assumption of a herbal remedy / M. Viganò, P. Lampertico, M. Colombo. - In: European Journal of Gastroenterology and Hepatology. - ISSN 0954-691X. - 20:4(2008). - p....

Low risk of hepatitis B reactivatioin in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, RUMI, MARIAGRAZIA, VIGANO', MAURO, AGHEMO, ALESSIO MICHELE, IAVARONE, MASSIMO ALBERTO, ...

Low risk of hepatitis B reactivatioin in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin / A. Aghemo, M. Viganò, M. Iavarone,...

Low risk of hepatitis B reactivation in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, RUMI, MARIAGRAZIA, IAVARONE, MASSIMO ALBERTO, AGHEMO, ALESSIO MICHELE, ...

Low risk of hepatitis B reactivation in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin / M. Iavarone, A. Aghemo, M. Viganò,...

Prospective study of dysplastic nodes in cirrhotic patients : correlation with CT vascular pattern (2008)

COLOMBO, MASSIMO, AGHEMO, ALESSIO MICHELE, LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO

Prospective study of dysplastic nodes in cirrhotic patients : correlation with CT vascular pattern / M. Iavarone, A. Sangiovanni, G. Ronchi, L.V. Forzenigo, A. Aghemo, P. Lampertico, M. Colombo. -...

The natural history of portal hypertension in patients with HCV related compensated cirrhosis undergoing interferon ribavirin therapy (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, RUMI, MARIAGRAZIA, AGHEMO, ALESSIO MICHELE, D'AMBROSIO, ROBERTA, DELL'ERA, ALESSANDRA, ...

The natural history of portal hypertension in patients with HCV related compensated cirrhosis undergoing interferon ribavirin therapy / R. D’Ambrosio, A. Aghemo, M.G. Rumi, M. Primignani, A....

Graft dysfunction (GD) in HBV recurrence free recipience is associated with serum autoantibodies reactivity (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, ROSSI, GIORGIO ETTORE, AROSIO, ELIANA

Graft dysfunction (GD) in HBV recurrence free recipience is associated with serum autoantibodies reactivity / M.F. Donato, E. Arosio, F. Agnelli, C. Rigamonti, M. Viganò, L. Caccamo, P. Lampertico,...

Independent predictors of discordance between transient elastography (TE) and liver biopsy (LB) (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, RUMI, MARIAGRAZIA, CONTE, DARIO

Independent predictors of discordance between transient elastography (TE) and liver biopsy (LB) / M. Fraquelli, C. Rigamonti, D. Conte, G. Casazza, M.F. Donato, M.G. Rumi, P. Lampertico, G. Ronchi,...

Low risk of hepatocellular carcinoma recurrence after liver transplantation : a 3-year follow-up study in 78 patients with chronic hepatitis B (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, ROSSI, GIORGIO ETTORE

Low risk of hepatocellular carcinoma recurrence after liver transplantation : a 3-year follow-up study in 78 patients with chronic hepatitis B / P. Lampertico, M. Viganò, S. Bhoori, F. Agnelli, M.F....

Add on Adefovir prevents the emergence of ADV resistance in Lamivudine-resistant patients : a 4-year study (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Add on Adefovir prevents the emergence of ADV resistance in Lamivudine-resistant patients : a 4-year study / P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, M. Colombo. - In: Journal of...

Independent predictors of discordance between transient elastography (TE) and liver biopsy (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, RUMI, MARIAGRAZIA, CONTE, DARIO

Independent predictors of discordance between transient elastography (TE) and liver biopsy / M. Fraquelli, C. Rigamonti, G. Casazza, M.F. Donato, D. Conte, S. Massironi, M.G. Rumi, P. Lampertico, G....

Very early add-on adefovir therapy in patients with sub-optimal virological response to lamivudine (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Very early add-on adefovir therapy in patients with sub-optimal virological response to lamivudine / M. Viganò, M. Iavarone, M. Colombo, P. Lampertico. - In: Digestive and liver disease : an...

Maintained HBV suppression in lamivudine-resistant patients treated with adefovir and lamivudine combination : A 4- year cohort study in 63 patients (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Maintained HBV suppression in lamivudine-resistant patients treated with adefovir and lamivudine combination : A 4- year cohort study in 63 patients / P. Lampertico, M. Viganò, E. Manenti, M....

Excellent 5-year overall survival in patients with HBV-related cirrhosis undergoing liver transplantation for hepatocellular carcinoma (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, BHOORI, SHERRIE, BONGINI, MARCO ANGELO, ...

Excellent 5-year overall survival in patients with HBV-related cirrhosis undergoing liver transplantation for hepatocellular carcinoma / P. Lampertico, M. Viganò, S. Bhoori, F. Agnelli, M.F. Donato,...

Progressive decline of HBsAg titers in longterm virological responders to nucleos(t)ide analogue therapy for chronic hepatitis B (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Progressive decline of HBsAg titers in longterm virological responders to nucleos(t)ide analogue therapy for chronic hepatitis B / M. Iavarone, P. Lampertico, M. Viganò, F. Facchetti, S. Melotti, G....

Transient elastography (TE) accurately predicts liver fibrosis stage in patients with chronic hepatitis B (2008)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, CONTE, DARIO, PIROLA, LORENA, ...

Transient elastography (TE) accurately predicts liver fibrosis stage in patients with chronic hepatitis B / M. Viganò, S. Massironi, P. Lampertico, S. Paggi, M. Iavarone, L. Pirola, P. Del Poggio,...

Low resistance to adefovir combined with lamivudine : a 3-year study of 145 lamivudine-resistant hepatitis B patients (2007)

MANENTI, ELENA, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, COLOMBO, MASSIMO, LAMPERTICO, PIETRO

Low resistance to adefovir combined with lamivudine : a 3-year study of 145 lamivudine-resistant hepatitis B patients / P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, E. Sablon, M. Colombo. -...

Natural history and clinical impact of cryoglobulins in chronic hepatitis C : 10-year prospective study of 343 patients (2007)

MAGGIONI, LORENA MARIA, VIGANO', MAURO, LAMPERTICO, PIETRO, RUMI, MARIAGRAZIA, MORABITO, ALBERTO, DEL NINNO, ERSILIO, ...

Natural history and clinical impact of cryoglobulins in chronic hepatitis C : 10-year prospective study of 343 patients / M. Viganò, P. Lampertico, M.G. Rumi, C. Folli L. Maggioni, A. Morabito, E....

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma (2007)

COLOMBO, MASSIMO, IAVARONE, MASSIMO ALBERTO, LAMPERTICO, PIETRO, IANNUZZI, FRANCESCA, MANENTI, ELENA, AROSIO, ELIANA, ...

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma / M. Iavarone, P. Lampertico, F. Iannuzzi, E. Manenti, M.F. Donato, E. Arosio, F. Bertolini, M....

Natural history and clinical impact of cryoglobulins in chronic hepatitis c: 10-year prospective study of 343 patients (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, RUMI, MARIAGRAZIA, MAGGIONI, LORENA MARIA, MORABITO, ALBERTO, ...

Natural history and clinical impact of cryoglobulins in chronic hepatitis c: 10-year prospective study of 343 patients / M. Viganò, P. Lampertico, M.G. Rumi, C. Folli, L. Maggioni, A. Morabito, E....

Low resistance to Adefovir combined with Lamivudine : a 3 year study of 145 Lamivudine resistant hepatitis B patients (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO

Low resistance to Adefovir combined with Lamivudine: A 3 year study of 145 Lamivudine resistant hepatitis B patients / P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, E. Sablon, M. Colombo. - In:...

Neoplasie del fegato (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, M. Colombo, P. Lampertico

Neoplasie del fegato / M. Colombo, P. Lampertico. - In: Manuale di Gastroenterologia / UNIGASTRO. - Roma : Editrice gastroenterologica italiana, 2007. - ISBN 887781814X. - p. 362-369.

3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, ...

3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients / P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, G. Lunghi, E....

Six years of on demand LAM +/- ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with hbeag-negative cirrhosis (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, DE FRANCHIS, ROBERTO, ...

Six years of on demand LAM +/- ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with hbeag-negative cirrhosis / M. Iavarone, P....

3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, ...

3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients / P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, G. Lunghi, E....

Six years of “on demand” LAM ± ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with HBeAg-negative cirrhosis (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, DE FRANCHIS, ROBERTO

Six years of “on demand” LAM ± ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with HBeAg-negative cirrhosis / M. Iavarone, P....

Natural history of HCC developing in HBV-related cirrhotic patients undergoing antiviral treatment with nucleos(t)ide analogues (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Natural history of HCC developing in HBV-related cirrhotic patients undergoing antiviral treatment with nucleos(t)ide analogues / M. Viganò, P. Lampertico, M. Iavarone, A. Sangiovanni, E. Del Ninno,...

Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B (2007)

LAMPERTICO, PIETRO

Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B / P. Lampertico, A. Marzano, M. Levrero, T....

Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B (2007)

LAMPERTICO, PIETRO

Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B / P. Lampertico, A. Marzano, M. Levrero, T....

On-treatment virologic suppression at week 24 decreases the risk of histologic progression at 1 year; Data from the globe trial (2007)

LAMPERTICO, PIETRO

On-treatment virologic suppression at week 24 decreases the risk of histologic progression at 1 year; Data from the globe trial / Y. Benhamou, A.M. Di Bisceglie, Z.D. Goodman, P. Lampertico, M.P....

Six years of "on demand" LAM plus ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with HBeAg-negative cirrhosis (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, DE FRANCHIS, ROBERTO, ...

Six years of "on demand" LAM plus ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with HBeAg-negative cirrhosis / M. Iavarone, P....

Low body mass index (BMI) predicts discordance between transient elastography (TE) and liver biopsy (LB) assessment of liver fibrosis (2007)

COLOMBO, MASSIMO, RUMI, MARIAGRAZIA, CONTE, DARIO, LAMPERTICO, PIETRO, CASAZZA, GIOVANNI, ...

Low body mass index (BMI) predicts discordance between transient elastography (TE) and liver biopsy (LB) assessment of liver fibrosis / M. Fraquelli, C. Rigamonti, G. Casazza, M.F. Donato, D. Conte,...

Prophylaxis and treatment of hepatitis B in immunocompromised patients (2007)

LAMPERTICO, PIETRO

Prophylaxis and treatment of hepatitis B in immunocompromised patients / A. Marzano, E. Angelucci, P. Andreone, M. Brunetto, R. Bruno, P. Burra, P. Caraceni, B. Daniele, V. Di Marco, F. Fabrizi, S....

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage (2007)

LAMPERTICO, PIETRO

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage / C. Dunn, M. Brunetto, G. Reynolds, T. Christophides, P.T. Kennedy, P. Lampertico, A....

Natural History and Clinical Impact of Cryoglobulins in Chronic Hepatitis C : 10-Year Prospective Study of 343 Patients (2007)

CICARDI, MARCO, LAMPERTICO, PIETRO, RUMI, MARIAGRAZIA, MAGGIONI, LORENA MARIA, MORABITO, ALBERTO, DEL NINNO, ERSILIO, ...

Natural History and Clinical Impact of Cryoglobulins in Chronic Hepatitis C : 10-Year Prospective Study of 343 Patients / M. Vigano, P. Lampertico, M.G. Rumi, C. Folli, L. Maggioni, A. Morabito, E....

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma (2007)

COLOMBO, MASSIMO, IAVARONE, MASSIMO ALBERTO, LAMPERTICO, PIETRO, IANNUZZI, FRANCESCA, MANENTI, ELENA, AROSIO, ELIANA, ...

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma / M. Iavarone, P. Lampertico, F. Iannuzzi, E. Manenti, M.F. Donato, E. Arosio, F. Bertolini, M....

Neoplasie del fegato (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, M. Colombo, P. Lampertico

Neoplasie del fegato / M. Colombo, P. Lampertico. - In: Manuale di Gastroenterologia / UNIGASTRO. - Roma : Editrice gastroenterologica italiana, 2007. - ISBN 887781814X. - p. 362-369.

3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, ...

3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients / P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, G. Lunghi, E....

Six years of on demand LAM +/- ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with hbeag-negative cirrhosis (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, DE FRANCHIS, ROBERTO, ...

Six years of on demand LAM +/- ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with hbeag-negative cirrhosis / M. Iavarone, P....

3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, ...

3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients / P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, G. Lunghi, E....

Six years of “on demand” LAM ± ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with HBeAg-negative cirrhosis (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, DE FRANCHIS, ROBERTO

Six years of “on demand” LAM ± ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with HBeAg-negative cirrhosis / M. Iavarone, P....

Natural history of HCC developing in HBV-related cirrhotic patients undergoing antiviral treatment with nucleos(t)ide analogues (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Natural history of HCC developing in HBV-related cirrhotic patients undergoing antiviral treatment with nucleos(t)ide analogues / M. Viganò, P. Lampertico, M. Iavarone, A. Sangiovanni, E. Del Ninno,...

Six years of "on demand" LAM plus ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with HBeAg-negative cirrhosis (2007)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO, DE FRANCHIS, ROBERTO, ...

Six years of "on demand" LAM plus ADV combination therapy significantly reduces the development and progression of esophageal varices in patients with HBeAg-negative cirrhosis / M. Iavarone, P....

Low body mass index (BMI) predicts discordance between transient elastography (TE) and liver biopsy (LB) assessment of liver fibrosis (2007)

COLOMBO, MASSIMO, RUMI, MARIAGRAZIA, CONTE, DARIO, LAMPERTICO, PIETRO, CASAZZA, GIOVANNI, ...

Low body mass index (BMI) predicts discordance between transient elastography (TE) and liver biopsy (LB) assessment of liver fibrosis / M. Fraquelli, C. Rigamonti, G. Casazza, M.F. Donato, D. Conte,...

Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H (2006)

CORTELEZZI, AGOSTINO, COLOMBO, MASSIMO, LAMPERTICO, PIETRO, ZILIOLI, VITTORIO RUGGERO, VIGANO', MAURO, PASQUINI, MARIA CRISTINA, ...

Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H / Agostino Cortelezzi, Mauro Viganò, Vittorio...

High rates of hepatitis B virus riverse seroconversion in anti-HBc carriers undergoing allogeneic bone marrow transplantation (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, LAMBERTENGHI DELILIERS, GIORGIO, SOLIGO, DAVIDE, VENER, CLAUDIA, ...

High rates of hepatitis B virus riverse seroconversion in anti-HBc carriers undergoing allogeneic bone marrow transplantation / Mauro Viganò, Claudia Vener, Davide Soligo, F. Lanfranchi, Giorgio...

No evidence for ADV resistance in HBeAg negative lamivudine resisstant patients treated with lamivudine-adefovir combination for 3 years (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, MANENTI, ELENA

No evidence for ADV resistance in HBeAg negative lamivudine resisstant patients treated with lamivudine-adefovir combination for 3 years / Pietro Lampertico, Mauro Viganò, Elena Manenti, E. Del...

Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H (2006)

CORTELEZZI, AGOSTINO, COLOMBO, MASSIMO, LAMPERTICO, PIETRO, ZILIOLI, VITTORIO RUGGERO, VIGANO', MAURO, PASQUINI, MARIA CRISTINA, ...

Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H / Agostino Cortelezzi, Mauro Viganò, Vittorio...

High rates of hepatitis B virus riverse seroconversion in anti-HBc carriers undergoing allogeneic bone marrow transplantation (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, LAMBERTENGHI DELILIERS, GIORGIO, SOLIGO, DAVIDE, VENER, CLAUDIA, ...

High rates of hepatitis B virus riverse seroconversion in anti-HBc carriers undergoing allogeneic bone marrow transplantation / Mauro Viganò, Claudia Vener, Davide Soligo, F. Lanfranchi, Giorgio...

No evidence for ADV resistance in HBeAg negative lamivudine resisstant patients treated with lamivudine-adefovir combination for 3 years (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, MANENTI, ELENA

No evidence for ADV resistance in HBeAg negative lamivudine resisstant patients treated with lamivudine-adefovir combination for 3 years / Pietro Lampertico, Mauro Viganò, Elena Manenti, E. Del...

Combination therapy with adefovir dipivoxil (ADV)and lamivudine (LAM) in LAM-resistant patients enlisted for liver transplantation (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, MANENTI, ELENA, VIGANO', MAURO

Combination therapy with adefovir dipivoxil (ADV)and lamivudine (LAM) in LAM-resistant patients enlisted for liver transplantation / M. Viganò, V. Mazzaferro, E. Manenti, R. Romito, G. Lunghi, A....

Entecavir vs lamivudine for HBeAg positive and negative chronic hepatitis B (2006)

LAMPERTICO, PIETRO, P. Lampertico

Entecavir vs lamivudine for HBeAg positive and negative chronic hepatitis B [Recensione] / P. Lampertico. - In: Journal of hepatology. - ISSN 0168-8278. - 45:3(2006). - p. 457-460.

Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, FARGION, SILVIA ROSSANA

Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients / Giovanni Raimondo, Maurizia R. Brunetto, Patrizia Pontisso,...

The international autoimmune hepatitis group scoring system in patients with chronic hepatitis C and serum autoantibodies undergoing interferon/ribavirin therapy : a prospective validation study (2006)

COLOMBO, MASSIMO, RUMI, MARIAGRAZIA, LAMPERTICO, PIETRO, MONTI, VALENTINA, D'AMBROSIO, ROBERTA, AROSIO, ELIANA, ...

The international autoimmune hepatitis group scoring system in patients with chronic hepatitis C and serum autoantibodies undergoing interferon/ribavirin therapy : a prospective validation study /...

Low rates of genotypic resistance to adefovir in lamivudine resistant patients treated with adefovir-lamivudine combination therapy for 3 years (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, ...

Low rates of genotypic resistance to adefovir in lamivudine resistant patients treated with adefovir-lamivudine combination therapy for 3 years / Pietro Lampertico, Mauro Viganò, Massimo Iavarone,...

No evidence for ADV resistance in HBeAg-negative Lamivudine resistant patients treated with LAMIVUDINE-ADEFOVIR combination for 3 years (2006)

COLOMBO, MASSIMO, VIGANO', MAURO, MANENTI, ELENA, LAMPERTICO, PIETRO

No evidence for ADV resistance in HBeAg-negative Lamivudine resistant patients treated with LAMIVUDINE-ADEFOVIR combination for 3 years / M Viganò, E Manenti, E Del Ninno, M Colombo, P Lampertico. -...

Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, VENER, CLAUDIA, SOLIGO, DAVIDE, LAMBERTENGHI DELILIERS, GIORGIO, ...

Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation / M. Viganò, C. Vener, D. Soligo, M. Colombo, F. Lanfranchi, G. Lambertenghi Deliliers, P. Lampertico....

Combination therapy with adefovir dipivoxil (ADV)and lamivudine (LAM) in LAM-resistant patients enlisted for liver transplantation (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, MANENTI, ELENA, VIGANO', MAURO

Combination therapy with adefovir dipivoxil (ADV)and lamivudine (LAM) in LAM-resistant patients enlisted for liver transplantation / M. Viganò, V. Mazzaferro, E. Manenti, R. Romito, G. Lunghi, A....

Entecavir vs lamivudine for HBeAg positive and negative chronic hepatitis B (2006)

LAMPERTICO, PIETRO, P. Lampertico

Entecavir vs lamivudine for HBeAg positive and negative chronic hepatitis B [Recensione] / P. Lampertico. - In: Journal of hepatology. - ISSN 0168-8278. - 45:3(2006). - p. 457-460.

Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, FARGION, SILVIA ROSSANA

Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients / Giovanni Raimondo, Maurizia R. Brunetto, Patrizia Pontisso,...

The international autoimmune hepatitis group scoring system in patients with chronic hepatitis C and serum autoantibodies undergoing interferon/ribavirin therapy : a prospective validation study (2006)

COLOMBO, MASSIMO, RUMI, MARIAGRAZIA, LAMPERTICO, PIETRO, MONTI, VALENTINA, D'AMBROSIO, ROBERTA, AROSIO, ELIANA, ...

The international autoimmune hepatitis group scoring system in patients with chronic hepatitis C and serum autoantibodies undergoing interferon/ribavirin therapy : a prospective validation study /...

Low rates of genotypic resistance to adefovir in lamivudine resistant patients treated with adefovir-lamivudine combination therapy for 3 years (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, ...

Low rates of genotypic resistance to adefovir in lamivudine resistant patients treated with adefovir-lamivudine combination therapy for 3 years / Pietro Lampertico, Mauro Viganò, Massimo Iavarone,...

No evidence for ADV resistance in HBeAg-negative Lamivudine resistant patients treated with LAMIVUDINE-ADEFOVIR combination for 3 years (2006)

COLOMBO, MASSIMO, VIGANO', MAURO, MANENTI, ELENA, LAMPERTICO, PIETRO

No evidence for ADV resistance in HBeAg-negative Lamivudine resistant patients treated with LAMIVUDINE-ADEFOVIR combination for 3 years / M Viganò, E Manenti, E Del Ninno, M Colombo, P Lampertico. -...

Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation (2006)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO, VENER, CLAUDIA, SOLIGO, DAVIDE, LAMBERTENGHI DELILIERS, GIORGIO, ...

Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation / M. Viganò, C. Vener, D. Soligo, M. Colombo, F. Lanfranchi, G. Lambertenghi Deliliers, P. Lampertico....

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine (2005)

MANENTI, ELENA, COLOMBO, MASSIMO, LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO, VIGANO', MAURO

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine / P. Lampertico, M. Viganò, E. Manenti, M.A. Iavarone, G. Lunghi, M. Colombo. - In:...

Review article : hepatitis C virus infection and type-2 diabetes mellitus in renal disease and transplantation (2005)

LAMPERTICO, PIETRO

Review article : hepatitis C virus infection and type-2 diabetes mellitus in renal disease and transplantation / F. Fabrizi, Pietro Lampertico, Giovanna Lunghi, S. Mangano, F. Aucella, P. Martin. -...

Review article : hepatitis C virus infection and type-2 diabetes mellitus in renal disease and transplantation (2005)

LAMPERTICO, PIETRO

Review article : hepatitis C virus infection and type-2 diabetes mellitus in renal disease and transplantation / F. Fabrizi, Pietro Lampertico, Giovanna Lunghi, S. Mangano, F. Aucella, P. Martin. -...

Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, MANENTI, ELENA

Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis / Mauro Viganò, Massimo Colombo, Adriana Aroldi, Giovanna Lunghi, Elena Manenti, Claudio...

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants / Alfredo Marzano, Pietro Lampertico, Vincenzo Mazzaferro, Silvia Carenzi, Mauro...

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine (2005)

COLOMBO, MASSIMO, MANENTI, ELENA, LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine / Pietro Lampertico, Mauro Viganò, Elena Manenti, Massimo Alberto Iavarone, Giovanna...

Natural history of hepatitis B and C in renal allograft recipients (2005)

LAMPERTICO, PIETRO

Natural history of hepatitis B and C in renal allograft recipients / Adriana Aroldi, Pietro Lampertico, Giuseppe Montagnino, Patrizia Passerini, Margherita Villa, Maria R. Campise, Giovanna Lunghi,...

Natural history of hepatitis C virus infection in adult renal graft recipients (2005)

LAMPERTICO, PIETRO

Natural history of hepatitis C virus infection in adult renal graft recipients / Adriana Aroldi, Pietro Lampertico, Giuseppe Montagnino, Giovanna Lunghi, Patrizia Passerini, Margherita Villa, Maria...

Lamivudine for chronic hepatitis B (2005)

LAMPERTICO, PIETRO, Pietro Lampertico, M. Buti, R. Esteban

Lamivudine for chronic hepatitis B / Pietro Lampertico. - In: Hepatitis B / M. Buti, R. Esteban. - Barcelona : Permanyer Publication, 2005. - p. 69-76.

IMPACT OF IFN ON PROGRESSION OF LIVER DISEASE IN HEPATITIS B “E” ANTIGEN (HBEAG) NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS: A LONG TERM ITALIAN MULTICENTER A.I.S.F. STUDY. (2005)

LAMPERTICO, PIETRO

IMPACT OF IFN ON PROGRESSION OF LIVER DISEASE IN HEPATITIS B “E” ANTIGEN (HBEAG) NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS: A LONG TERM ITALIAN MULTICENTER A.I.S.F. STUDY. / Filippo Oliveri,...

A multicenter italian study of rescue Adefovir Dipivoxil therapy in Lamivudine resistant patients : a 2-year analysis of 604 patients (2005)

LAMPERTICO, PIETRO

A multicenter italian study of rescue Adefovir Dipivoxil therapy in Lamivudine resistant patients : a 2-year analysis of 604 patients / Pietro Lampertico, Alfredo Marzano, Massimo Levrero, Teresa...

Immunomodulatory effects of the large fluctuations in IFN-alpha and IL-8 accompanying hepatic flares in anti-HBe chronic HBV patients (2005)

LAMPERTICO, PIETRO

Immunomodulatory effects of the large fluctuations in IFN-alpha and IL-8 accompanying hepatic flares in anti-HBe chronic HBV patients / C. Dunn, Maurizia R. Brunetto, D. Flichman, Pietro Lampertico,...

IFN impact on liver disease progression in HBeAg negative chronic hepatitis B (CHB): a long term Italian Multicenter AISF study (2005)

LAMPERTICO, PIETRO

IFN impact on liver disease progression in HBeAg negative chronic hepatitis B (CHB): a long term Italian Multicenter AISF study / Filippo Oliveri, Massimo Puoti, Teresa Santantonio, Pietro...

IFN impact on liver disease progression in HBeAg negative chronic hepatitis B (CHB) : a long term Italian Multicenter AISF study (2005)

LAMPERTICO, PIETRO

IFN impact on liver disease progression in HBeAg negative chronic hepatitis B (CHB) : a long term Italian Multicenter AISF study / Filippo Oliveri, Massimo Puoti, Teresa Santantonio, Pietro...

Increased survival of patients with HCV-related cirrhosis with a long-term response to interferon therapy (2005)

COLOMBO, MASSIMO, IAVARONE, MASSIMO ALBERTO, RUMI, MARIAGRAZIA, LAMPERTICO, PIETRO, AGHEMO, ALESSIO MICHELE

Increased survival of patients with HCV-related cirrhosis with a long-term response to interferon therapy / Mauro Vigano`, Alessio Aghemo, Massimo Alberto Iavarone, Pietro Lampertico, Maria Grazia...

Inhibition of HBV-replication by combined treatment of lamivudine and adefovir dipivoxil allows long-term campath-1H therapy in refractory B-cell chronic lymphoblastic leukemia (2005)

LAMBERTENGHI DELILIERS, GIORGIO, VIGANO', MAURO, CORTELEZZI, AGOSTINO, ZILIOLI, VITTORIO RUGGERO, PASQUINI, MARIA CRISTINA, COLOMBO, MASSIMO, ...

Inhibition of HBV-replication by combined treatment of lamivudine and adefovir dipivoxil allows long-term campath-1H therapy in refractory B-cell chronic lymphoblastic leukemia / A. Cortelezzi, M....

Five years of sequential lam to lam_adv therapy suppresses HBV replication in most hbeag-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma (2005)

COLOMBO, MASSIMO, VIGANO', MAURO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, LAMPERTICO, PIETRO

Five years of sequential lam to lam_adv therapy suppresses HBV replication in most hbeag-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma / Pietro Lampertico, Mauro...

Prophylaxis of hepatitis B virus recurrence after liver transplantation (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO

Prophylaxis of hepatitis B virus recurrence after liver transplantation / Alfredo Marzano, Pietro Lampertico, Vincenzo Mazzaferro, S. Saia, Mauro Viganò, Raffaele Romito, A. Pulvirenti, A....

Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistano patients with HBeAg-negative chronic hepatitis B (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO, MANENTI, ELENA, VIGANO', MAURO

Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistano patients with HBeAg-negative chronic hepatitis B / Pietro Lampertico, Mauro Viganò, Elena...

Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, VIGANO', MAURO

Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B / Pietro Lampertico, Mauro Viganò, Elena...

Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, VIGANO', MAURO

Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy / Pietro Lampertico, Mauro Viganò, Elena Manenti, Giovanna Lunghi,...

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants / Alfredo Marzano, Pietro Lampertico, Vincenzo Mazzaferro, S. Saia, Mauro Viganò,...

Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, MANENTI, ELENA, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy / Pietro Lampertico, Mauro Viganò, Elena Manenti, Giovanni Lunghi,...

Combined lamivudine and adefovir dipivoxil treatment allows safe and long-term compath-1H therapy in refractory B-cell chronic lymphocytic leukemia with HBV reactivation (2005)

CORTELEZZI, AGOSTINO, VIGANO', MAURO, ZILIOLI, VITTORIO RUGGERO, PASQUINI, MARIA CRISTINA, COLOMBO, MASSIMO, LAMBERTENGHI DELILIERS, GIORGIO, ...

Combined lamivudine and adefovir dipivoxil treatment allows safe and long-term compath-1H therapy in refractory B-cell chronic lymphocytic leukemia with HBV reactivation / A. Cortelezzi, M. Viganò,...

Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, MANENTI, ELENA, VIGANO', MAURO

Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis / Mauro Viganò, Massimo Colombo, Adriana Aroldi, Giovanna Lunghi, Elena Manenti, Claudio...

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants / Alfredo Marzano, Pietro Lampertico, Vincenzo Mazzaferro, Silvia Carenzi, Mauro...

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine (2005)

COLOMBO, MASSIMO, MANENTI, ELENA, LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine / Pietro Lampertico, Mauro Viganò, Elena Manenti, Massimo Alberto Iavarone, Giovanna...

Natural history of hepatitis B and C in renal allograft recipients (2005)

LAMPERTICO, PIETRO

Natural history of hepatitis B and C in renal allograft recipients / Adriana Aroldi, Pietro Lampertico, Giuseppe Montagnino, Patrizia Passerini, Margherita Villa, Maria R. Campise, Giovanna Lunghi,...

Natural history of hepatitis C virus infection in adult renal graft recipients (2005)

LAMPERTICO, PIETRO

Natural history of hepatitis C virus infection in adult renal graft recipients / Adriana Aroldi, Pietro Lampertico, Giuseppe Montagnino, Giovanna Lunghi, Patrizia Passerini, Margherita Villa, Maria...

Lamivudine for chronic hepatitis B (2005)

LAMPERTICO, PIETRO, Pietro Lampertico, M. Buti, R. Esteban

Lamivudine for chronic hepatitis B / Pietro Lampertico. - In: Hepatitis B / M. Buti, R. Esteban. - Barcelona : Permanyer Publication, 2005. - p. 69-76.

IMPACT OF IFN ON PROGRESSION OF LIVER DISEASE IN HEPATITIS B “E” ANTIGEN (HBEAG) NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS: A LONG TERM ITALIAN MULTICENTER A.I.S.F. STUDY. (2005)

LAMPERTICO, PIETRO

IMPACT OF IFN ON PROGRESSION OF LIVER DISEASE IN HEPATITIS B “E” ANTIGEN (HBEAG) NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS: A LONG TERM ITALIAN MULTICENTER A.I.S.F. STUDY. / Filippo Oliveri,...

A multicenter italian study of rescue Adefovir Dipivoxil therapy in Lamivudine resistant patients : a 2-year analysis of 604 patients (2005)

LAMPERTICO, PIETRO

A multicenter italian study of rescue Adefovir Dipivoxil therapy in Lamivudine resistant patients : a 2-year analysis of 604 patients / Pietro Lampertico, Alfredo Marzano, Massimo Levrero, Teresa...

Immunomodulatory effects of the large fluctuations in IFN-alpha and IL-8 accompanying hepatic flares in anti-HBe chronic HBV patients (2005)

LAMPERTICO, PIETRO

Immunomodulatory effects of the large fluctuations in IFN-alpha and IL-8 accompanying hepatic flares in anti-HBe chronic HBV patients / C. Dunn, Maurizia R. Brunetto, D. Flichman, Pietro Lampertico,...

IFN impact on liver disease progression in HBeAg negative chronic hepatitis B (CHB): a long term Italian Multicenter AISF study (2005)

LAMPERTICO, PIETRO

IFN impact on liver disease progression in HBeAg negative chronic hepatitis B (CHB): a long term Italian Multicenter AISF study / Filippo Oliveri, Massimo Puoti, Teresa Santantonio, Pietro...

IFN impact on liver disease progression in HBeAg negative chronic hepatitis B (CHB) : a long term Italian Multicenter AISF study (2005)

LAMPERTICO, PIETRO

IFN impact on liver disease progression in HBeAg negative chronic hepatitis B (CHB) : a long term Italian Multicenter AISF study / Filippo Oliveri, Massimo Puoti, Teresa Santantonio, Pietro...

Increased survival of patients with HCV-related cirrhosis with a long-term response to interferon therapy (2005)

COLOMBO, MASSIMO, IAVARONE, MASSIMO ALBERTO, RUMI, MARIAGRAZIA, LAMPERTICO, PIETRO, AGHEMO, ALESSIO MICHELE

Increased survival of patients with HCV-related cirrhosis with a long-term response to interferon therapy / Mauro Vigano`, Alessio Aghemo, Massimo Alberto Iavarone, Pietro Lampertico, Maria Grazia...

Inhibition of HBV-replication by combined treatment of lamivudine and adefovir dipivoxil allows long-term campath-1H therapy in refractory B-cell chronic lymphoblastic leukemia (2005)

LAMBERTENGHI DELILIERS, GIORGIO, VIGANO', MAURO, CORTELEZZI, AGOSTINO, ZILIOLI, VITTORIO RUGGERO, PASQUINI, MARIA CRISTINA, COLOMBO, MASSIMO, ...

Inhibition of HBV-replication by combined treatment of lamivudine and adefovir dipivoxil allows long-term campath-1H therapy in refractory B-cell chronic lymphoblastic leukemia / A. Cortelezzi, M....

Five years of sequential lam to lam_adv therapy suppresses HBV replication in most hbeag-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma (2005)

COLOMBO, MASSIMO, VIGANO', MAURO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, LAMPERTICO, PIETRO

Five years of sequential lam to lam_adv therapy suppresses HBV replication in most hbeag-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma / Pietro Lampertico, Mauro...

Prophylaxis of hepatitis B virus recurrence after liver transplantation (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO

Prophylaxis of hepatitis B virus recurrence after liver transplantation / Alfredo Marzano, Pietro Lampertico, Vincenzo Mazzaferro, S. Saia, Mauro Viganò, Raffaele Romito, A. Pulvirenti, A....

Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistano patients with HBeAg-negative chronic hepatitis B (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO, MANENTI, ELENA, VIGANO', MAURO

Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistano patients with HBeAg-negative chronic hepatitis B / Pietro Lampertico, Mauro Viganò, Elena...

Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, VIGANO', MAURO

Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B / Pietro Lampertico, Mauro Viganò, Elena...

Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, MANENTI, ELENA, IAVARONE, MASSIMO ALBERTO, VIGANO', MAURO

Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy / Pietro Lampertico, Mauro Viganò, Elena Manenti, Giovanna Lunghi,...

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, VIGANO', MAURO

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants / Alfredo Marzano, Pietro Lampertico, Vincenzo Mazzaferro, S. Saia, Mauro Viganò,...

Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy (2005)

COLOMBO, MASSIMO, LAMPERTICO, PIETRO, MANENTI, ELENA, VIGANO', MAURO, IAVARONE, MASSIMO ALBERTO

Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy / Pietro Lampertico, Mauro Viganò, Elena Manenti, Giovanni Lunghi,...

Combined lamivudine and adefovir dipivoxil treatment allows safe and long-term compath-1H therapy in refractory B-cell chronic lymphocytic leukemia with HBV reactivation (2005)

CORTELEZZI, AGOSTINO, VIGANO', MAURO, ZILIOLI, VITTORIO RUGGERO, PASQUINI, MARIA CRISTINA, COLOMBO, MASSIMO, LAMBERTENGHI DELILIERS, GIORGIO, ...

Combined lamivudine and adefovir dipivoxil treatment allows safe and long-term compath-1H therapy in refractory B-cell chronic lymphocytic leukemia with HBV reactivation / A. Cortelezzi, M. Viganò,...

Assessing tumor angiogenesis : Increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells (2004)

LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO

Assessing tumor angiogenesis : Increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells / C. Rabascio, E. Muratori, P. Mancuso, A. Calleri,...

Assessing tumor angiogenesis : Increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells (2004)

LAMPERTICO, PIETRO, IAVARONE, MASSIMO ALBERTO

Assessing tumor angiogenesis : Increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells / C. Rabascio, E. Muratori, P. Mancuso, A. Calleri,...

Clinical outcome of HBeAg-negtive chronic hepatitis B in relation to virological response to lamivudine (2004)

LAMPERTICO, PIETRO

Clinical outcome of HBeAg-negtive chronic hepatitis B in relation to virological response to lamivudine / Vito Di Marco, Alfredo Marzano, Pietro Lampertico, P. Andreone, Teresa Santantonio, Piero L....

Clinical outcome of HBeAg-negtive chronic hepatitis B in relation to virological response to lamivudine (2004)

LAMPERTICO, PIETRO

Clinical outcome of HBeAg-negtive chronic hepatitis B in relation to virological response to lamivudine / Vito Di Marco, Alfredo Marzano, Pietro Lampertico, P. Andreone, Teresa Santantonio, Piero L....

Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation (2003)

LAMPERTICO, PIETRO

Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation / S. Beckebaum, Massimo Malagò, O. Dirsch, VR. Cicinnati,...

Long-term suppression of hepatitis B e antigen negative chronic hepatitis B by 24 months interferon therapy (2003)

LAMPERTICO, PIETRO, COLOMBO, MASSIMO, MORABITO, ALBERTO

Long-term suppression of hepatitis B e antigen negative chronic hepatitis B by 24 months interferon therapy / Pietro Lampertico, Ersilio Del Ninno, Mauro Viganò, Raffaella Romeo, Maria Francesca...

Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation (2003)

LAMPERTICO, PIETRO

Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation / S. Beckebaum, Massimo Malagò, O. Dirsch, VR. Cicinnati,...

Long-term suppression of hepatitis B e antigen negative chronic hepatitis B by 24 months interferon therapy (2003)

LAMPERTICO, PIETRO, COLOMBO, MASSIMO, MORABITO, ALBERTO

Long-term suppression of hepatitis B e antigen negative chronic hepatitis B by 24 months interferon therapy / Pietro Lampertico, Ersilio Del Ninno, Mauro Viganò, Raffaella Romeo, Maria Francesca...

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage

Dunn, Claire, Brunetto, Maurizia, Reynolds, Gary, Christophides, Theodoros, Kennedy, Patrick T., Lampertico, Pietro, ...

Hepatitis B virus (HBV) causes chronic infection in more than 350 million people worldwide. It replicates in hepatocytes but is non-cytopathic; liver damage is thought to be immune mediated. Here, we...